We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$4.57B
AUM Growth
+$359M
Cap. Flow
+$74.8M
Cap. Flow %
1.64%
Top 10 Hldgs %
35.25%
Holding
741
New
48
Increased
297
Reduced
285
Closed
32

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$10M
2
CB icon
Chubb
CB
+$9.49M
3
AMT icon
American Tower
AMT
+$8.28M
4
ATEC icon
Alphatec Holdings
ATEC
+$7.1M
5
GLP icon
Global Partners
GLP
+$5.7M

Sector Composition

Rank Sector Weight
1 Technology 18.23%
2 Industrials 11.43%
3 Financials 10.99%
4 Healthcare 8.9%
5 Consumer Discretionary 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMP
676
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$203K ﹤0.01%
14,000
XEL icon
677
Xcel Energy
XEL
$51B
$202K ﹤0.01%
3,066
+11
+0.4% +$766
MDB icon
678
MongoDB
MDB
$24B
$201K ﹤0.01%
+555
New +$172K
PINS icon
679
Pinterest
PINS
$12.4B
$200K ﹤0.01%
+2,532
New +$177K
HLAHU
680
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Unit
HLAHU
$198K ﹤0.01%
+19,700
New +$197K
DBD
681
DELISTED
Diebold Nixdorf Incorporated
DBD
$190K ﹤0.01%
14,780
FLR icon
682
Fluor
FLR
$7.29B
$177K ﹤0.01%
10,000
AMX icon
683
America Movil
AMX
$78.1B
$173K ﹤0.01%
11,551
SH icon
684
ProShares Short S&P500
SH
$887M
$171K ﹤0.01%
2,778
-25
-0.9% -$1.59K
CLOV icon
685
Clover Health Investments
CLOV
$2.28B
$164K ﹤0.01%
12,307
-217,614
-95% -$2.14M
URGN icon
686
UroGen Pharma
URGN
$2B
$153K ﹤0.01%
10,041
PTVE
687
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$151K ﹤0.01%
10,000
CERS icon
688
Cerus
CERS
$587M
$148K ﹤0.01%
25,000
KLDO
689
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$140K ﹤0.01%
18,800
+300
+2% +$2.13K
EVM
690
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
$126K ﹤0.01%
10,532
SYRE icon
691
Spyre Therapeutics
SYRE
$8.87B
$125K ﹤0.01%
+720
New +$131K
SDS icon
692
ProShares UltraShort S&P500
SDS
$406M
$113K ﹤0.01%
500
IVC
693
DELISTED
Invacare Corporation
IVC
$113K ﹤0.01%
13,988
SRTA
694
Strata Critical Medical Inc
SRTA
$436M
$105K ﹤0.01%
+10,000
New +$98.7K
SRNG
695
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
$101K ﹤0.01%
+10,100
New +$101K
VIV icon
696
Telefônica Brasil
VIV
$22.4B
$99K ﹤0.01%
+11,645
New +$97.7K
PIPP
697
DELISTED
Pine Island Acquisition Corp.
PIPP
$97K ﹤0.01%
10,000
MTNB icon
698
Matinas BioPharma
MTNB
$1.55M
$95K ﹤0.01%
2,460
PNNT
699
Pennant Park Investment Corp
PNNT
$215M
$84K ﹤0.01%
12,640
-2,950
-19% -$19.3K
LAB icon
700
Standard BioTools
LAB
$326M
$75K ﹤0.01%
12,110
+10
+0.1% +$53

Similar funds

Cerity Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Cerity Partners held 741 positions worth $4.57B, up 8.5% from $4.21B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Cerity Partners's Q2 2021 filing shows 48 new, 297 increased, 285 reduced and 32 closed positions. Its largest new stake was Steris: 67,948 shares worth $14M. The largest sale was Ansys, an estimated $10M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Cerity Partners's largest Q2 2021 buy was Steris: 67,948 shares worth $14M.
  • Cerity Partners added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $19.4M increase.
  • Cerity Partners's biggest Q2 2021 reduction was Ansys, cutting an estimated $10M.
  • Cerity Partners fully exited State Street Health Care Select Sector SPDR ETF in Q2 2021, selling an estimated $1.87M.
  • Cerity Partners's ten largest holdings make up 35% of its $4.57B portfolio in Q2 2021.
  • Cerity Partners opened 48 new positions and closed 32 in Q2 2021.
  • Cerity Partners's portfolio value rose 8.5% quarter-over-quarter to $4.57B.

Based on Cerity Partners's 13F filing for Q2 2021, filed 11 Aug 2021.